Anti-LCMV Glycoprotein GP1 Antibody from ProteoGenix; catalogue ARO-A22034; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-LCMV Glycoprotein GP1 Antibody is a highly specific and sensitive tool for detecting the glycoprotein GP1 of the lymphocytic choriomeningitis virus (LCMV). This antibody is designed for use in a variety of biotech applications, including immunohistochemistry, flow cytometry, and Western blotting.
The main function of this antibody is to bind to the GP1 protein of LCMV, allowing for the detection and quantification of the virus in biological samples. This makes it an essential tool for researchers studying the pathogenesis and immune response of LCMV, as well as for diagnostic purposes.
In addition to its use in basic research, the Anti-LCMV Glycoprotein GP1 Antibody has also been successfully employed in experimental treatments for LCMV infections. By targeting the GP1 protein, this antibody can potentially block the virus from entering and infecting host cells, providing a potential therapeutic avenue for LCMV-related diseases.
With its high specificity and sensitivity, this antibody has been extensively validated for use in a variety of experimental settings. Whether you are studying the pathogenesis of LCMV, developing new diagnostic methods, or exploring potential treatments, the Anti-LCMV Glycoprotein GP1 Antibody is an invaluable tool for your research.
In summary, the Anti-LCMV Glycoprotein GP1 Antibody is a powerful and versatile tool for detecting and studying the glycoprotein GP1 of LCMV. Its high specificity and sensitivity, along with its various applications and experimental use cases, make it an essential component of any biotech research arsenal. Order now and take your LCMV research to the next level.
ProteoGenix catalogue number ARO-A22034. For research use only.
Target: GP1; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| GP1 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
